ACS Publications. Most Trusted. Most Cited. Most Read
Targeted Therapy of Atherosclerosis by a Broad-Spectrum Reactive Oxygen Species Scavenging Nanoparticle with Intrinsic Anti-inflammatory Activity
My Activity
    Article

    Targeted Therapy of Atherosclerosis by a Broad-Spectrum Reactive Oxygen Species Scavenging Nanoparticle with Intrinsic Anti-inflammatory Activity
    Click to copy article linkArticle link copied!

    • Yuquan Wang
      Yuquan Wang
      Department of Cardiology, Southwest Hospital  and  Department of Pharmaceutics, College of Pharmacy, Third Military Medical University, Chongqing 400038, China
      Department of Cardiology, Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, China
      More by Yuquan Wang
    • Lanlan Li
      Lanlan Li
      Department of Pharmaceutics, College of Pharmacy, Third Military Medical University, Chongqing 400038, China
      More by Lanlan Li
    • Weibo Zhao
      Weibo Zhao
      Department of Cardiology, Southwest Hospital, Third Military Medical University, Chongqing 400038, China
      More by Weibo Zhao
    • Yin Dou
      Yin Dou
      Department of Pharmaceutics, College of Pharmacy, Third Military Medical University, Chongqing 400038, China
      More by Yin Dou
    • Huijie An
      Huijie An
      Department of Pharmaceutics, College of Pharmacy, Third Military Medical University, Chongqing 400038, China
      More by Huijie An
    • Hui Tao
      Hui Tao
      Department of Pharmaceutics, College of Pharmacy, Third Military Medical University, Chongqing 400038, China
      More by Hui Tao
    • Xiaoqiu Xu
      Xiaoqiu Xu
      Department of Pharmaceutics, College of Pharmacy, Third Military Medical University, Chongqing 400038, China
      More by Xiaoqiu Xu
    • Yi Jia
      Yi Jia
      Department of Pharmaceutics, College of Pharmacy, Third Military Medical University, Chongqing 400038, China
      More by Yi Jia
    • Shan Lu
      Shan Lu
      Department of Pharmaceutics, College of Pharmacy, Third Military Medical University, Chongqing 400038, China
      More by Shan Lu
    • Jianxiang Zhang*
      Jianxiang Zhang
      Department of Pharmaceutics, College of Pharmacy, Third Military Medical University, Chongqing 400038, China
      *E-mail: [email protected] or [email protected]
    • Houyuan Hu*
      Houyuan Hu
      Department of Cardiology, Southwest Hospital, Third Military Medical University, Chongqing 400038, China
      *E-mail: [email protected]
      More by Houyuan Hu
    Other Access OptionsSupporting Information (1)

    ACS Nano

    Cite this: ACS Nano 2018, 12, 9, 8943–8960
    Click to copy citationCitation copied!
    https://doi.org/10.1021/acsnano.8b02037
    Published August 16, 2018
    Copyright © 2018 American Chemical Society

    Abstract

    Click to copy section linkSection link copied!
    Abstract Image

    Atherosclerosis is a leading cause of vascular diseases worldwide. Whereas antioxidative therapy has been considered promising for the treatment of atherosclerosis in view of a critical role of reactive oxygen species (ROS) in the pathogenesis of atherosclerosis, currently available antioxidants showed considerably limited clinical outcomes. Herein, we hypothesize that a broad-spectrum ROS-scavenging nanoparticle can serve as an effective therapy for atherosclerosis, taking advantage of its antioxidative stress activity and targeting effects. As a proof of concept, a broad-spectrum ROS-eliminating material was synthesized by covalently conjugating a superoxide dismutase mimetic agent Tempol and a hydrogen-peroxide-eliminating compound of phenylboronic acid pinacol ester onto a cyclic polysaccharide β-cyclodextrin (abbreviated as TPCD). TPCD could be easily processed into a nanoparticle (TPCD NP). The obtained nanotherapy TPCD NP could be efficiently and rapidly internalized by macrophages and vascular smooth muscle cells (VSMCs). TPCD NPs significantly attenuated ROS-induced inflammation and cell apoptosis in macrophages, by eliminating overproduced intracellular ROS. Also, TPCD NPs effectively inhibited foam cell formation in macrophages and VSMCs by decreasing internalization of oxidized low-density lipoprotein. After intravenous (i.v.) administration, TPCD NPs accumulated in atherosclerotic lesions of apolipoprotein E-deficient (ApoE–/–) mice by passive targeting through the dysfunctional endothelium and translocation via inflammatory cells. TPCD NPs significantly inhibited the development of atherosclerosis in ApoE–/– mice after i.v. delivery. More importantly, therapy with TPCD NPs afforded stabilized plaques with less cholesterol crystals, a smaller necrotic core, thicker fibrous cap, and lower macrophages and matrix metalloproteinase-9, compared with those treated with control drugs previously developed for antiatherosclerosis. The therapeutic benefits of TPCD NPs mainly resulted from reduced systemic and local oxidative stress and inflammation as well as decreased inflammatory cell infiltration in atherosclerotic plaques. Preliminary in vivo tests implied that TPCD NPs were safe after long-term treatment via i.v. injection. Consequently, TPCD NPs can be developed as a potential antiatherosclerotic nanotherapy.

    Copyright © 2018 American Chemical Society

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.

    Recommended

    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. Add or change your institution or let them know you’d like them to include access.

    Supporting Information

    Click to copy section linkSection link copied!

    The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/acsnano.8b02037.

    • Supplementary results, including Figures S1–S18 (PDF)

    Terms & Conditions

    Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: http://pubs.acs.org/page/copyright/permissions.html.

    Cited By

    Click to copy section linkSection link copied!

    This article is cited by 259 publications.

    1. Cui Tang, Hui Wang, Lina Guo, Yimin Cui, Chan Zou, Jianming Hu, Hanyong Zhang, Guoping Yang, Wenhu Zhou. Multifunctional Nanomedicine for Targeted Atherosclerosis Therapy: Activating Plaque Clearance Cascade and Suppressing Inflammation. ACS Nano 2025, Article ASAP.
    2. Huaner Ni, Hui Zhou, Xin Liang, Yulong Ge, Hangwei Chen, Junyi Liu, Ben Wang, Huiyu Chen, Yujing Zhang, Sihan Luo, Ying Chen, Xiaomei Lu, Chao Yin, Quli Fan. Reactive Oxygen Species-Responsive Nanoparticle Delivery of Small Interfering Ribonucleic Acid Targeting Olfactory Receptor 2 for Atherosclerosis Theranostics. ACS Nano 2024, 18 (34) , 23599-23614. https://doi.org/10.1021/acsnano.4c07988
    3. Li Zhu, Yuan Zhong, Meng Yan, Sheng Ni, Xiong Zhao, Shuai Wu, Guixue Wang, Kun Zhang, Qingjia Chi, Xian Qin, Chuanwei Li, Xiaobei Huang, Wei Wu. Macrophage Membrane-Encapsulated Dopamine-Modified Poly Cyclodextrin Multifunctional Biomimetic Nanoparticles for Atherosclerosis Therapy. ACS Applied Materials & Interfaces 2024, 16 (25) , 32027-32044. https://doi.org/10.1021/acsami.4c04431
    4. Jinyuan Liu, Xiao Yu, Annaliese Braucht, Steve Smith, Congzhou Wang. N-Cadherin Targeted Melanin Nanoparticles Reverse the Endothelial–Mesenchymal Transition in Vascular Endothelial Cells to Potentially Slow the Progression of Atherosclerosis and Cancer. ACS Nano 2024, 18 (11) , 8229-8247. https://doi.org/10.1021/acsnano.3c12281
    5. Yuxuan Ma, Qi Wang, Shiyu Du, Jingwei Luo, Xiaolei Sun, Bin Jia, Jingru Ge, Jun Dong, Shuoxing Jiang, Zhe Li. Multipathway Regulation for Targeted Atherosclerosis Therapy Using Anti-miR-33-Loaded DNA Origami. ACS Nano 2024, 18 (7) , 5418-5433. https://doi.org/10.1021/acsnano.3c10213
    6. Han Li, Xiaoyu Xia, Jiachen Zang, Shuzhen Cheng, Xianbing Xu, Zhenyu Wang, Ming Du. Construction of Manganese-Based Oyster (Crassostrea gigas) Ferritin Nanozyme with Catalase-like Enzyme Activity. Journal of Agricultural and Food Chemistry 2024, 72 (1) , 810-818. https://doi.org/10.1021/acs.jafc.3c07661
    7. Cui Tang, Hui Wang, Lina Guo, Chan Zou, Jianming Hu, Hanyong Zhang, Wenhu Zhou, Guoping Yang. CpG-Conjugated Silver Nanoparticles as a Multifunctional Nanomedicine to Promote Macrophage Efferocytosis and Repolarization for Atherosclerosis Therapy. ACS Applied Materials & Interfaces 2023, 15 (45) , 52162-52179. https://doi.org/10.1021/acsami.3c11227
    8. Hongliang He, Qinggong Han, Shi Wang, Mengmeng Long, Miao Zhang, Yan Li, Yu Zhang, Ning Gu. Design of a Multifunctional Nanozyme for Resolving the Proinflammatory Plaque Microenvironment and Attenuating Atherosclerosis. ACS Nano 2023, 17 (15) , 14555-14571. https://doi.org/10.1021/acsnano.3c01420
    9. Feng Han, Zhengdong Tu, Zhuang Zhu, Dachuan Liu, Qingchen Meng, Qifan Yu, Ying Wang, Jianquan Chen, Tao Liu, Fengxuan Han, Bin Li. Targeting Endogenous Reactive Oxygen Species Removal and Regulating Regenerative Microenvironment at Annulus Fibrosus Defects Promote Tissue Repair. ACS Nano 2023, 17 (8) , 7645-7661. https://doi.org/10.1021/acsnano.3c00093
    10. Le Qu, Hanjiao Chen, Hongyu Chen, Chengjia Shi, Huaqing Li, Wenru Lian, Meixin Mao, Yan Hou, Qi Ai, Huige Yang, Xinhao Yan, Xuying Liu, Xiaoguang Hu. Nanoparticles Containing Biocompatible Radicals Based on 1,2,4-Benzotriazinyl for Reactive Oxygen Species Scavenging in Living Cells. ACS Applied Nano Materials 2023, 6 (7) , 5781-5788. https://doi.org/10.1021/acsanm.3c00209
    11. Yuan Gao, Shihong Liu, Xinchun Zeng, Zhixiong Guo, Da Chen, Sanzhong Li, Zhimin Tian, Yongquan Qu. Reduction of Reactive Oxygen Species Accumulation Using Gadolinium-Doped Ceria for the Alleviation of Atherosclerosis. ACS Applied Materials & Interfaces 2023, 15 (8) , 10414-10425. https://doi.org/10.1021/acsami.2c20492
    12. Shuo Wang, Yuequan Wang, Xiaoxue Lai, Jianwen Sun, Miao Hu, Meng Chen, Cong Li, Feng Xu, Chuizhong Fan, Xinrong Liu, Yanzhi Song, Guoliang Chen, Yihui Deng. Minimalist Nanocomplex with Dual Regulation of Endothelial Function and Inflammation for Targeted Therapy of Inflammatory Vascular Diseases. ACS Nano 2023, 17 (3) , 2761-2781. https://doi.org/10.1021/acsnano.2c11058
    13. Ruizhi Hu, Chen Dai, Caihong Dong, Li Ding, Hui Huang, Yu Chen, Bo Zhang. Living Macrophage-Delivered Tetrapod PdH Nanoenzyme for Targeted Atherosclerosis Management by ROS Scavenging, Hydrogen Anti-inflammation, and Autophagy Activation. ACS Nano 2022, 16 (10) , 15959-15976. https://doi.org/10.1021/acsnano.2c03422
    14. Anas Ahmad, Ravi Prakash, Mohd Shahnawaz Khan, Nojood Altwaijry, Muhammad Nadeem Asghar, Syed Shadab Raza, Rehan Khan. Enhanced Antioxidant Effects of Naringenin Nanoparticles Synthesized using the High-Energy Ball Milling Method. ACS Omega 2022, 7 (38) , 34476-34484. https://doi.org/10.1021/acsomega.2c04148
    15. Yue Zhou, Siyu Wang, Xiaoyang Liang, Zbynek Heger, Min Xu, Qiang Lu, Meng Yu, Vojtech Adam, Nan Li. Turning Hot into Cold: Immune Microenvironment Reshaping for Atherosclerosis Attenuation Based on pH-Responsive shSiglec-1 Delivery System. ACS Nano 2022, 16 (7) , 10517-10533. https://doi.org/10.1021/acsnano.2c01778
    16. Runze Zhao, Xiaoyue Ning, Mengqi Wang, Huanhuan Wang, Guang Xing, Li Wang, Chengzhi Lu, Ao Yu, Yongjian Wang. A ROS-Responsive Simvastatin Nano-Prodrug and its Fibronectin-Targeted Co-Delivery System for Atherosclerosis Treatment. ACS Applied Materials & Interfaces 2022, 14 (22) , 25080-25092. https://doi.org/10.1021/acsami.2c02354
    17. Suya Zhang, Lulu Ning, Zhihui Song, Xinyue Zhao, Feng Guan, Xiao-Feng Yang, Jianjian Zhang. Activatable Near-Infrared Fluorescent Organic Nanoprobe for Hypochlorous Acid Detection in the Early Diagnosis of Rheumatoid Arthritis. Analytical Chemistry 2022, 94 (15) , 5805-5813. https://doi.org/10.1021/acs.analchem.1c05184
    18. Min He, Qian Wang, Yunbo Feng, Xinghui Gao, Chao He, Jiangge Li, Weifeng Zhao, Weidong Tian, Changsheng Zhao. Spatiotemporal Management of the Osteoimmunomodulation of Fibrous Scaffolds by Loading a Novel Amphiphilic Nanomedicine. ACS Applied Materials & Interfaces 2022, 14 (12) , 13991-14003. https://doi.org/10.1021/acsami.1c20809
    19. Sunkui Ke, Peiyan Yang, Yange Wang, Shefang Ye, Shengbin Kou. Flower-Like Molybdenum Disulfide Nanostructures for Promoting Mitochondrial Homeostasis and Attenuating Inflammatory Endothelial Dysfunction. ACS Applied Nano Materials 2021, 4 (11) , 11709-11722. https://doi.org/10.1021/acsanm.1c02315
    20. Jichao Yuan, Lanlan Li, Qinghua Yang, Hong Ran, Jie Wang, Kaiyao Hu, Wendan Pu, Jialu Huang, Lan Wen, Linke Zhou, Ying Jiang, Xiaoxing Xiong, Jianxiang Zhang, Zhenhua Zhou. Targeted Treatment of Ischemic Stroke by Bioactive Nanoparticle-Derived Reactive Oxygen Species Responsive and Inflammation-Resolving Nanotherapies. ACS Nano 2021, 15 (10) , 16076-16094. https://doi.org/10.1021/acsnano.1c04753
    21. Wentao Fan, Shuo Zhang, Yuting Wu, Tao Lu, Jiwen Liu, Xiuyun Cao, Shuhui Liu, Liping Yan, Xizhi Shi, Guangliang Liu, Chaobo Huang, Suquan Song. Genistein-Derived ROS-Responsive Nanoparticles Relieve Colitis by Regulating Mucosal Homeostasis. ACS Applied Materials & Interfaces 2021, 13 (34) , 40249-40266. https://doi.org/10.1021/acsami.1c09215
    22. Boxuan Ma, Hong Xu, Yanan Wang, Li Yang, Weihua Zhuang, Gaocan Li, Yunbing Wang. Biomimetic-Coated Nanoplatform with Lipid-Specific Imaging and ROS Responsiveness for Atherosclerosis-Targeted Theranostics. ACS Applied Materials & Interfaces 2021, 13 (30) , 35410-35421. https://doi.org/10.1021/acsami.1c08552
    23. Jiawei Li, Huiqiang Qiu, Hengtai Gong, Weijun Tong. Broad-Spectrum Reactive Oxygen Species Scavenging and Activated Macrophage-Targeting Microparticles Ameliorate Inflammatory Bowel Disease. Biomacromolecules 2021, 22 (7) , 3107-3118. https://doi.org/10.1021/acs.biomac.1c00551
    24. Xiaoyun Li, Rui Wu, Huan Chen, Ting Li, Huiming Jiang, Xingquan Xu, Xueting Tang, Mimi Wan, Chun Mao, Dongquan Shi. Near-Infrared Light-Driven Multifunctional Tubular Micromotors for Treatment of Atherosclerosis. ACS Applied Materials & Interfaces 2021, 13 (26) , 30930-30940. https://doi.org/10.1021/acsami.1c03600
    25. Carlisle R. DeJulius, Bryan R. Dollinger, Taylor E. Kavanaugh, Eric Dailing, Fang Yu, Shubham Gulati, Angelo Miskalis, Caiyun Zhang, Jashim Uddin, Sergey Dikalov, Craig L. Duvall. Optimizing an Antioxidant TEMPO Copolymer for Reactive Oxygen Species Scavenging and Anti-Inflammatory Effects in Vivo. Bioconjugate Chemistry 2021, 32 (5) , 928-941. https://doi.org/10.1021/acs.bioconjchem.1c00081
    26. Ying Liu, Yiqiong Liu, Jie Zang, Abdullah Abdullah Isam Abdullah, Yongyong Li, Haiqing Dong. Design Strategies and Applications of ROS-Responsive Phenylborate Ester-Based Nanomedicine. ACS Biomaterials Science & Engineering 2020, 6 (12) , 6510-6527. https://doi.org/10.1021/acsbiomaterials.0c01190
    27. Hyejoong Jeong, Daheui Choi, Junjira Tanum, Yoogyeong Oh, Kyungtae Park, Jinkee Hong. Nanocrystals Continuously Releasing Nitric Oxide: Promoting Cell Migration and Increasing Cell Survival against Oxidative Stress. Chemistry of Materials 2020, 32 (22) , 9787-9797. https://doi.org/10.1021/acs.chemmater.0c03800
    28. Huaiyuan Zhao, Hengshu Ye, Jun Zhou, Guping Tang, Zhaoyin Hou, Hongzhen Bai. Montmorillonite-Enveloped Zeolitic Imidazolate Framework as a Nourishing Oral Nano-Platform for Gastrointestinal Drug Delivery. ACS Applied Materials & Interfaces 2020, 12 (44) , 49431-49441. https://doi.org/10.1021/acsami.0c15494
    29. Huibo Wang, MengLing Zhang, Yurong Ma, Bo Wang, Hui Huang, Yang Liu, Mingwang Shao, Zhenhui Kang. Carbon Dots Derived from Citric Acid and Glutathione as a Highly Efficient Intracellular Reactive Oxygen Species Scavenger for Alleviating the Lipopolysaccharide-Induced Inflammation in Macrophages. ACS Applied Materials & Interfaces 2020, 12 (37) , 41088-41095. https://doi.org/10.1021/acsami.0c11735
    30. Yin Long, Hao Wei, Jun Li, Mengting Li, Yizhan Wang, Ziyi Zhang, Tianye Cao, Corey Carlos, Lazarus G. German, Dawei Jiang, Tuanwei Sun, Jonathan W. Engle, Xiaoli Lan, Yadong Jiang, Weibo Cai, Xudong Wang. Prevention of Hepatic Ischemia-Reperfusion Injury by Carbohydrate-Derived Nanoantioxidants. Nano Letters 2020, 20 (9) , 6510-6519. https://doi.org/10.1021/acs.nanolett.0c02248
    31. Zhicheng Le, Zhijia Liu, Lilong Sun, Lixin Liu, Yongming Chen. Augmenting Therapeutic Potential of Polyphenols by Hydrogen-Bonding Complexation for the Treatment of Acute Lung Inflammation. ACS Applied Bio Materials 2020, 3 (8) , 5202-5212. https://doi.org/10.1021/acsabm.0c00616
    32. Yan Wang, Lanlan Li, Yongchang Ma, Yong Tang, Yang Zhao, Zimeng Li, Wendan Pu, Bo Huang, Xuan Wen, Xiaojuan Cao, Jiafei Chen, Wei Chen, Yue Zhou, Jianxiang Zhang. Multifunctional Supramolecular Hydrogel for Prevention of Epidural Adhesion after Laminectomy. ACS Nano 2020, 14 (7) , 8202-8219. https://doi.org/10.1021/acsnano.0c01658
    33. Boxuan Ma, Hong Xu, Weihua Zhuang, Yanan Wang, Gaocan Li, Yunbing Wang. Reactive Oxygen Species Responsive Theranostic Nanoplatform for Two-Photon Aggregation-Induced Emission Imaging and Therapy of Acute and Chronic Inflammation. ACS Nano 2020, 14 (5) , 5862-5873. https://doi.org/10.1021/acsnano.0c01012
    34. Yixuan Tang, Xiaoyou Wang, Jie Li, Yu Nie, Guojian Liao, Yang Yu, Chong Li. Overcoming the Reticuloendothelial System Barrier to Drug Delivery with a “Don’t-Eat-Us” Strategy. ACS Nano 2019, 13 (11) , 13015-13026. https://doi.org/10.1021/acsnano.9b05679
    35. Li Yu, He-Liang Ke, Fu-Sheng Du, Zi-Chen Li. Redox-Responsive Fluorescent Polycarbonates Based on Selenide for Chemotherapy of Triple-Negative Breast Cancer. Biomacromolecules 2019, 20 (7) , 2809-2820. https://doi.org/10.1021/acs.biomac.9b00583
    36. Bowen Yang, Yu Chen, Jianlin Shi. Reactive Oxygen Species (ROS)-Based Nanomedicine. Chemical Reviews 2019, 119 (8) , 4881-4985. https://doi.org/10.1021/acs.chemrev.8b00626
    37. Abhijit Lincon, Sandeep Kumar Yadav, Subhayan Das, Mahitosh Mandal, Sunando DasGupta, Soumen Das. Capturing in-vitro electro-mechanochemical signals in a label-free drug testing system for atherosclerosis. Sensors and Actuators B: Chemical 2025, 427 , 137182. https://doi.org/10.1016/j.snb.2024.137182
    38. Wei Zhao, Yu Zhang, Jing Chen, Danrong Hu. Revolutionizing oral care: Reactive oxygen species (ROS)-Regulating biomaterials for combating infection and inflammation. Redox Biology 2025, 79 , 103451. https://doi.org/10.1016/j.redox.2024.103451
    39. Chinmaya Mahapatra. Redox nanotherapeutics: Fundamentals and applications. 2025, 229-268. https://doi.org/10.1016/B978-0-443-22257-3.00011-8
    40. Xiangjun Zhang, Xiaodi Yang, Yan Wang, Zhongping Xu, Sisi Yi, Tao Guo, Yue Liao, Xiyu Tang, Jianxiang Zhang, Ruibing Wang. A supramolecular nanoprodrug for prevention of gallstone formation. Chinese Chemical Letters 2025, 36 (2) , 109854. https://doi.org/10.1016/j.cclet.2024.109854
    41. Shevanuja Theivendran, Chengzhong Yu. Nanomaterials for drug delivery, what’s next – Editorial. Next Materials 2025, 6 , 100341. https://doi.org/10.1016/j.nxmate.2024.100341
    42. Lin Yuan, Ying Li, Moutong Chen, Liang Xue, Juan Wang, Yu Ding, Qihui Gu, Jumei Zhang, Hui Zhao, Xinqiang Xie, Qingping Wu. Therapeutic applications of gut microbes in cardiometabolic diseases: current state and perspectives. Applied Microbiology and Biotechnology 2024, 108 (1) https://doi.org/10.1007/s00253-024-13007-7
    43. Yun Dai, Yifan Guo, Weicheng Tang, Dan Chen, Liru Xue, Ying Chen, Yican Guo, Simin Wei, Meng Wu, Jun Dai, Shixuan Wang. Reactive oxygen species-scavenging nanomaterials for the prevention and treatment of age-related diseases. Journal of Nanobiotechnology 2024, 22 (1) https://doi.org/10.1186/s12951-024-02501-9
    44. Xianghong Luo, Mengjiao Zhang, Waicong Dai, Xianghao Xiao, Xinyi Li, Yingjian Zhu, Xiangyang Shi, Zhaojun Li. Targeted nanoparticles triggered by plaque microenvironment for atherosclerosis treatment through cascade effects of reactive oxygen species scavenging and anti-inflammation. Journal of Nanobiotechnology 2024, 22 (1) https://doi.org/10.1186/s12951-024-02652-9
    45. Rebecca Fima, Sébastien Dussaud, Cheïma Benbida, Margault Blanchet, François Lanthiez, Lucie Poupel, Claudia Brambilla, Adélaïde Gélineau, Mattia Dessena, Marina Blanc, Cédric Lerévérend, Martine Moreau, Alexandre Boissonnas, Emmanuel L. Gautier, Thierry Huby. Loss of embryonically-derived Kupffer cells during hypercholesterolemia accelerates atherosclerosis development. Nature Communications 2024, 15 (1) https://doi.org/10.1038/s41467-024-52735-2
    46. Runze Yang, Liwei Yan, Tianhao Xu, Kaibo Zhang, Xiong Lu, Chaoming Xie, Weili Fu. Injectable bioadhesive hydrogel as a local nanomedicine depot for targeted regulation of inflammation and ferroptosis in rheumatoid arthritis. Biomaterials 2024, 311 , 122706. https://doi.org/10.1016/j.biomaterials.2024.122706
    47. Zhanhao Zhou, Hongbing Lan, Hongyuan Tan, Yi Wang, Wei Chen, Samira Batur, Chuansheng Fu, Li Kong, Conglian Yang, Boning Niu, Yuanyuan Guo, Zhiping Zhang, Kai Huang. ROS-responsive biomimetic nanovesicles to plaque microenvironment in targeted therapy of atherosclerosis. Nano Today 2024, 59 , 102530. https://doi.org/10.1016/j.nantod.2024.102530
    48. Zihao Wang, Mengyu Li, Jia Chen, Shengmin Zhang, Bin Wang, Jianglin Wang. Immunomodulatory Hydrogel for Electrostatically Capturing Pro‐inflammatory Factors and Chemically Scavenging Reactive Oxygen Species in Chronic Diabetic Wound Remodeling. Advanced Healthcare Materials 2024, 13 (31) https://doi.org/10.1002/adhm.202402080
    49. Huoli Hu, Wenjia Zhang, Yundong Zhou, Kui Zhao, Junjie Kuang, Xi Liu, Guoshu Li, Yong Xi. Engineered mitochondrial ROS scavenger nanocomplex to enhance lung biodistribution and reduce inflammation for the treatment of ARDS. Advanced Composites and Hybrid Materials 2024, 7 (6) https://doi.org/10.1007/s42114-024-00989-1
    50. Xi Yang, Jian Hu, Quanle Gao, Yiping Deng, Yilin Liu, Xinghui He, Chuang Li, Xin Yu, Ying Wan, Chao Pi, Yumeng Wei, Chunhong Li. Advances in nano-delivery systems based on diagnosis and theranostics strategy for atherosclerosis. Journal of Drug Targeting 2024, 63 , 1-16. https://doi.org/10.1080/1061186X.2024.2433560
    51. Mengying Cheng, Tianxiang Yue, Hong Wang, Lai Jiang, Qiaoling Huang, Fanzhu Li. Biomimetic nanoparticles co-deliver hirudin and lumbrukinase to ameliorate thrombus and inflammation for atherosclerosis therapy. Asian Journal of Pharmaceutical Sciences 2024, 185 , 100990. https://doi.org/10.1016/j.ajps.2024.100990
    52. Yuanzhe Lin, Jingjing Liu, Suet Yen Chong, Hui Jun Ting, Xichuan Tang, Liqiang Yang, Sitong Zhang, Xinyi Qi, Peng Pei, Zhigao Yi, Chenyuan Huang, Xiao Hou, Liang Gao, Federico Torta, Xiaogang Liu, Bin Liu, James Chen Yong Kah, Jiong‐Wei Wang. Dual‐Function Nanoscale Coordination Polymer Nanoparticles for Targeted Diagnosis and Therapeutic Delivery in Atherosclerosis. Small 2024, 20 (47) https://doi.org/10.1002/smll.202401659
    53. Ruifei Shao, Rui Chen, Qiang Zheng, Mengyu Yao, Kunlin Li, Yu Cao, Lihong Jiang. Oxidative stress disrupts vascular microenvironmental homeostasis affecting the development of atherosclerosis. Cell Biology International 2024, 13 https://doi.org/10.1002/cbin.12239
    54. Mishal Safdar, Muneeb Ullah, Shah Hamayun, Abdul Wahab, Shahid Ullah Khan, Sidikov Akmal Abdikakhorovich, Zia Ul Haq, Aqsa Mehreen, Muhammad Naeem, Apon Zaenal Mustopa, Nurhasni Hasan. Microbiome miracles and their pioneering advances and future frontiers in cardiovascular disease. Current Problems in Cardiology 2024, 49 (9) , 102686. https://doi.org/10.1016/j.cpcardiol.2024.102686
    55. Tingting Liu, Yanjun Chen, Lianjie Hou, Yulu Yu, Dan Ma, Ting Jiang, Guojun Zhao. Immune cell-mediated features of atherosclerosis. Frontiers in Cardiovascular Medicine 2024, 11 https://doi.org/10.3389/fcvm.2024.1450737
    56. Siyuan Xu, Xinya Huang, Yanyan Wang, Jianping Liu, Wenli Zhang. The effect of dual antioxidant modification on oxidative stress resistance and anti-dysfunction of non-split HDL and recombinant HDL. International Journal of Biological Macromolecules 2024, 5 , 134632. https://doi.org/10.1016/j.ijbiomac.2024.134632
    57. Sandeep Kumar Yadav, Karri Karthik, Manjunatha Mahadevappa, Soumen Das. Atorvastatin-based nanoparticle-decorated glyceryl monostearate as a targeted drug carrier for inhibition of atherosclerosis lesions. New Journal of Chemistry 2024, 48 (30) , 13444-13456. https://doi.org/10.1039/D4NJ01322K
    58. Yueqi Ni, Yuanyuan Hu, Lijia Zhu, Xulin Jiang, Hong Zhang, Jia Liu, Yin Zhao. Lycium Barbarum Polysaccharide‐Derived Nanoparticles Protect Visual Function by Inhibiting RGC Ferroptosis and Microglial Activation in Retinal Ischemia‒Reperfusion Mice. Advanced Healthcare Materials 2024, 27 https://doi.org/10.1002/adhm.202304285
    59. Cong Hu, Zhipengjun Zhang, Shanyi Sun, Hongwen Liu, Lin Yuan, Xiao-Bing Zhang. Progress and Perspective of Atherosclerosis-Targeted Molecular Probes: From Precise Imaging to Auxiliary Diagnosis and Treatment. Coordination Chemistry Reviews 2024, 510 , 215850. https://doi.org/10.1016/j.ccr.2024.215850
    60. Yinan Jia, Li Zhang, Junhua Xu, Lin Xiang. Recent advances in cell membrane camouflaged nanotherapeutics for the treatment of bacterial infection. Biomedical Materials 2024, 19 (4) , 042006. https://doi.org/10.1088/1748-605X/ad46d4
    61. Chenxing Fu, Ying Tao, Zechuan Li, Yuying Yao, Fangmei Lin, Dongyue He, Haoting Chen, Jing Ma, Yafang Xiao, Lu Liu, Xing-Jie Liang, Weisheng Guo. Circulating monocyte differentiation-activated nanoprodrugs for reprogramming macrophage immunity in atherosclerotic plaques. Nano Today 2024, 56 , 102304. https://doi.org/10.1016/j.nantod.2024.102304
    62. Heba A. Abou-Taleb, Randa Mohammed Zaki, Ahmed A. Hefny, Obaid Afzal, Mary Girgis Shahataa, Fatma I. Abo El-Ela, Heba F. Salem, Amr Gamal Fouad. In vitro and in vivo evaluation of isoxsuprine loaded invasomes for efficient treatment of diabetes‐accelerated atherosclerosis. Journal of Drug Delivery Science and Technology 2024, 96 , 105686. https://doi.org/10.1016/j.jddst.2024.105686
    63. Chenyao Wu, Lili Xia, Wei Feng, Yu Chen. MXene‐Mediated Catalytic Redox Reactions for Biomedical Applications. ChemPlusChem 2024, 89 (6) https://doi.org/10.1002/cplu.202300777
    64. Yuying Liu, Zeyu Jiang, Xiao Yang, Yin Wang, Bin Yang, Qinrui Fu. Engineering Nanoplatforms for Theranostics of Atherosclerotic Plaques. Advanced Healthcare Materials 2024, 13 (16) https://doi.org/10.1002/adhm.202303612
    65. Zishuo Zhou, Yaxue Liu, Pei Xie, Zongning Yin. A ROS-responsive multifunctional targeted prodrug micelle for atherosclerosis treatment. International Journal of Pharmaceutics 2024, 14 , 124352. https://doi.org/10.1016/j.ijpharm.2024.124352
    66. Qianying Jia, He Huang, Zhipei Tong, Liudang Fang, Qinggong Jia, Shijie Zhu, Yufeng Zheng, Shaokang Guan, Dong Bian, Hui Yu. Endothelium-Mimicking with NO-generating coating on bioabsorbable magnesium alloy for improving corrosion resistance and biological responses of vascular stents. Chemical Engineering Journal 2024, 490 , 151344. https://doi.org/10.1016/j.cej.2024.151344
    67. Haoguang Wu, Jie Sheng, Zhiyue Wang, Ziyue Zu, Kaiyan Xiang, Jianchen Qi, Zhicheng Wang, Guangming Lu, Longjiang Zhang. Tannic acid–poloxamer self-assembled nanoparticles for advanced atherosclerosis therapy by regulation of macrophage polarization. Journal of Materials Chemistry B 2024, 12 (19) , 4708-4716. https://doi.org/10.1039/D3TB01157G
    68. Shusen Bao, Dongmei Yu, Zhen Tang, Hao Wu, Hao Zhang, Ning Wang, Yichao Liu, Hai Huang, Chaozong Liu, Xiaokang Li, Zheng Guo. Conformationally regulated “nanozyme-like” cerium oxide with multiple free radical scavenging activities for osteoimmunology modulation and vascularized osseointegration. Bioactive Materials 2024, 34 , 64-79. https://doi.org/10.1016/j.bioactmat.2023.12.006
    69. Yi Liu, Qian Huang, Mengyun He, Tingting Chen, Xia Chu. A nano-bioconjugate modified with anti-SIRPα antibodies and antisense oligonucleotides of mTOR for anti-atherosclerosis therapy. Acta Biomaterialia 2024, 176 , 356-366. https://doi.org/10.1016/j.actbio.2023.12.031
    70. Skylar T. Chuang, Joshua B. Stein, Sarah Nevins, Cemile Kilic Bektas, Hye Kyu Choi, Wan‐Kyu Ko, Hyunjun Jang, Jihun Ha, Ki‐Bum Lee. Enhancing CAR Macrophage Efferocytosis Via Surface Engineered Lipid Nanoparticles Targeting LXR Signaling. Advanced Materials 2024, 286 https://doi.org/10.1002/adma.202308377
    71. Shuwen Zhou, Huijuan Cai, Xinjuan He, Zhiyong Tang, Siyu Lu. Enzyme-mimetic antioxidant nanomaterials for ROS scavenging: Design, classification, and biological applications. Coordination Chemistry Reviews 2024, 500 , 215536. https://doi.org/10.1016/j.ccr.2023.215536
    72. Qiao Chen, Xinmei Duan, Yao Yu, Rongrong Ni, Guojing Song, Xu Yang, Li Zhu, Yuan Zhong, Kun Zhang, Kai Qu, Xian Qin, Wei Wu. Target Functionalized Carbon Dot Nanozymes with Dual‐Model Photoacoustic and Fluorescence Imaging for Visual Therapy in Atherosclerosis. Advanced Science 2024, 11 (6) https://doi.org/10.1002/advs.202307441
    73. Sandeep Kumar Yadav, Shreyasi Das, Abhijit Lincon, Saradindu Saha, Somdeb BoseDasgupta, Samit K. Ray, Soumen Das. Gelatin-decorated Graphene oxide: A nanocarrier for delivering pH-responsive drug for improving therapeutic efficacy against atherosclerotic plaque. International Journal of Pharmaceutics 2024, 651 , 123737. https://doi.org/10.1016/j.ijpharm.2023.123737
    74. Liling Ou, Zixia Wu, Xiao Hu, Jinyi Huang, Zhiqi Yi, Zehua Gong, Huaqiong Li, Ke Peng, Chang Shu, Leo H. Koole. A tissue-adhesive F127 hydrogel delivers antioxidative copper-selenide nanoparticles for the treatment of dry eye disease. Acta Biomaterialia 2024, 175 , 353-368. https://doi.org/10.1016/j.actbio.2023.12.021
    75. Bo Deng, Shaomin Liu, Ying Wang, Barkat Ali, Na Kong, Tian Xie, Seyoung Koo, Jiang Ouyang, Wei Tao. Oral Nanomedicine: Challenges and Opportunities. Advanced Materials 2024, 36 (6) https://doi.org/10.1002/adma.202306081
    76. Xi Xu, Xiao-Dan Xu, Meng-Qing Ma, Yin Liang, Yang-Bo Cai, Zi-Xian Zhu, Tao Xu, Lin Zhu, Kun Ren. The mechanisms of ferroptosis and its role in atherosclerosis. Biomedicine & Pharmacotherapy 2024, 171 , 116112. https://doi.org/10.1016/j.biopha.2023.116112
    77. Weihong Ji, Yuanxing Zhang, Weichen Shao, Ranjith Kumar Kankala, Aizheng Chen. β-Cyclodextrin-based nanoassemblies for the treatment of atherosclerosis. Regenerative Biomaterials 2024, 11 https://doi.org/10.1093/rb/rbae071
    78. Dagmara Wojcik-Grzybek, Zbigniew Sliwowski, Slawomir Kwiecien, Grzegorz Ginter, Marcin Surmiak, Magdalena Hubalewska-Mazgaj, Anna Chmura, Adrianna Wojcik, Tomasz Kosciolek, Aleksandra Danielak, Aneta Targosz, Malgorzata Strzalka, Urszula Szczyrk, Agata Ptak-Belowska, Marcin Magierowski, Jan Bilski, Tomasz Brzozowski. Alkaline Phosphatase Relieves Colitis in Obese Mice Subjected to Forced Exercise via Its Anti-Inflammatory and Intestinal Microbiota-Shaping Properties. International Journal of Molecular Sciences 2024, 25 (2) , 703. https://doi.org/10.3390/ijms25020703
    79. Da-Gui Zhang, Yu-Jing Pan, Biao-Qi Chen, Xiao-Chang Lu, Qin-Xi Xu, Pei Wang, Ranjith Kumar Kankala, Ni-Na Jiang, Shi-Bin Wang, Ai-Zheng Chen. Protein-guided biomimetic nanomaterials: a versatile theranostic nanoplatform for biomedical applications. Nanoscale 2024, 45 https://doi.org/10.1039/D3NR05495K
    80. Yajun Song, Yang Li, Wengang Hu, Feng Li, Hao Sheng, Chibing Huang, Xin Gou, Jingming Hou, Ji Zheng, Ya Xiao. Luminol-conjugated cyclodextrin biological nanoparticles for the treatment of severe burn-induced intestinal barrier disruption. Burns & Trauma 2024, 12 https://doi.org/10.1093/burnst/tkad054
    81. Xiufang Jiang, Yanling Lei, Yajuan Yin, Fangfang Ma, Mingqi Zheng, Gang Liu. Fisetin Suppresses Atherosclerosis by Inhibiting Ferroptosis-Related Oxidative Stress in Apolipoprotein E Knockout Mice. Pharmacology 2024, 109 (3) , 169-179. https://doi.org/10.1159/000538535
    82. Rupam Khatua, Bibrita Bhar, Souradeep Dey, Chitra Jaiswal, Victoria J, Biman B. Mandal. Advances in engineered nanosystems: immunomodulatory interactions for therapeutic applications. Nanoscale 2024, 197 https://doi.org/10.1039/D4NR00680A
    83. Hao Kang, Fansu Meng, Fengjie Liu, Mengjie Xie, Haibiao Lai, Pengfei Li, Xingwang Zhang. Nanomedicines Targeting Ferroptosis to Treat Stress-Related Diseases. International Journal of Nanomedicine 2024, Volume 19 , 8189-8210. https://doi.org/10.2147/IJN.S476948
    84. Yanan Huang, Yunfeng Wang, Tianyu Zheng, Shuang Nie, Yanli Wang, Hui Shen, Fengfeng Mo. Development of Dual Diagnostic-Therapeutic Nanoformulation Effective Against Pancreatic Cancer in Animal Model. International Journal of Nanomedicine 2024, Volume 19 , 9121-9143. https://doi.org/10.2147/IJN.S464788
    85. Miaomiao Xu, Ying Cui, Siyuan Wei, Xuelong Cong, Yiying Chen, Shujie Tian, Anqi Yao, Weiwei Chen, Lixing Weng. Emerging nanomaterials targeting macrophage adapted to abnormal metabolism in cancer and atherosclerosis therapy (Review). International Journal of Molecular Medicine 2023, 53 (2) https://doi.org/10.3892/ijmm.2023.5337
    86. Jieqiong Cao, Yibo Zhang, Yiqi Yang, Junye Xie, Zijian Su, Fu Li, Jingsheng Li, Bihui Zhang, Zhenyu Wang, Peiguang Zhang, Zhixin Li, Liu He, Hongwei Liu, Wenjie Zheng, Shuixing Zhang, An Hong, Xiaojia Chen. Turning gray selenium and sublimed sulfur into a nanocomposite to accelerate tissue regeneration by isothermal recrystallization. Journal of Nanobiotechnology 2023, 21 (1) https://doi.org/10.1186/s12951-023-01796-4
    87. Yu Mao, Jun Ren, Lifang Yang. Advances of nanomedicine in treatment of atherosclerosis and thrombosis. Environmental Research 2023, 238 , 116637. https://doi.org/10.1016/j.envres.2023.116637
    88. Chengxi Wu, Jingying Mao, Xueqin Wang, Ronghao Yang, Chenglong Wang, Chunhong Li, Xiangyu Zhou. Advances in treatment strategies based on scavenging reactive oxygen species of nanoparticles for atherosclerosis. Journal of Nanobiotechnology 2023, 21 (1) https://doi.org/10.1186/s12951-023-02058-z
    89. Lanlan Li, Bingyu Chen, Gang Li, Sheng Chen, Jianxiang Zhang. Anti‐Inflammatory Nanotherapies Based on Bioactive Cyclodextrin Materials. Advanced NanoBiomed Research 2023, 3 (12) https://doi.org/10.1002/anbr.202300106
    90. Wen Xi Goh, Yih Yih Kok, Chiew Yen Wong. Comparison of Cell-based and Nanoparticle-based Therapeutics in Treating Atherosclerosis. Current Pharmaceutical Design 2023, 29 (35) , 2827-2840. https://doi.org/10.2174/0113816128272185231024115046
    91. Binura Perera, Yuao Wu, Nam-Trung Nguyen, Hang Thu Ta. Advances in drug delivery to atherosclerosis: Investigating the efficiency of different nanomaterials employed for different type of drugs. Materials Today Bio 2023, 22 , 100767. https://doi.org/10.1016/j.mtbio.2023.100767
    92. Liyuan Chen, Xue Wang, Chang Liu, Ping Deng, Lina Pan, Lingling Yang, Juan Cheng, Xutao Zhang, Russel J. Reiter, Zhengping Yu, Huifeng Pi, Zhou Zhou, Houyuan Hu. Melatonin ameliorates atherosclerosis by suppressing S100a9-mediated vascular inflammation. European Journal of Pharmacology 2023, 957 , 175965. https://doi.org/10.1016/j.ejphar.2023.175965
    93. Aiai Zhang, Kaijing Liu, Xiaoyu Liang, Huiyang Li, Xue Fu, Ni Zhu, Fangjiang Li, Jing Yang. Metal-phenolic capsules with ROS scavenging reshape the oxidative microenvironment of atherosclerosis. Nanomedicine: Nanotechnology, Biology and Medicine 2023, 53 , 102700. https://doi.org/10.1016/j.nano.2023.102700
    94. Majood Haddad, Alex N. Frickenstein, Stefan Wilhelm. High-throughput single-cell analysis of nanoparticle-cell interactions. TrAC Trends in Analytical Chemistry 2023, 166 , 117172. https://doi.org/10.1016/j.trac.2023.117172
    95. Ming-Yue Yang, Yi-Fan Tu, Ke-Ke Feng, Meng-Die Yin, Yi-Fan Fang, Jing-Qing Le, Bang-Yue Luo, Xia-Rong Tan, Jing-Wei Shao. A erythrocyte-platelet hybrid membrane coated biomimetic nanosystem based on ginsenosides and PFH combined with ultrasound for targeted delivery in thrombus therapy. Colloids and Surfaces B: Biointerfaces 2023, 229 , 113468. https://doi.org/10.1016/j.colsurfb.2023.113468
    96. Xiaoluan Lu, Zhongshan He, Xiao Xiao, Xuelian Wei, Xiangrong Song, Shiyong Zhang. Natural Antioxidant‐Based Nanodrug for Atherosclerosis Treatment. Small 2023, https://doi.org/10.1002/smll.202303459
    97. Lihui Xuan, Zhao Ju, Magdalena Skonieczna, Ping‐Kun Zhou, Ruixue Huang. Nanoparticles‐induced potential toxicity on human health: Applications, toxicity mechanisms, and evaluation models. MedComm 2023, 4 (4) https://doi.org/10.1002/mco2.327
    98. Seung-Woon Baek, Da-Seul Kim, Jun-Kyu Lee, Jun Hyuk Kim, Semi Lee, Jeong Min Park, So-Yeon Park, Duck Hyun Song, Chun Gwon Park, Dong Keun Han. Continuous NO dual-generation by ZnO nanoparticle conjugated with α-lipoic acid for functional biodegradable vascular stent. Chemical Engineering Journal 2023, 470 , 144174. https://doi.org/10.1016/j.cej.2023.144174
    99. Nan Wang, Kang-Kang Yu, Kun Li, Xiao-Qi Yu. A biocompatible polyethylene glycol/alginate composite hydrogel with significant reactive oxygen species consumption for promoting wound healing. Journal of Materials Chemistry B 2023, 11 (29) , 6934-6942. https://doi.org/10.1039/D3TB00771E
    100. Liyun Zhu, Wanru Xu, Emeli Chatterjee, Guoping Li, Xu Wang, Junjie Xiao, Xuerui Chen, Liming Yang. Anti-inflammation nanomedicine shots through atherosclerotic plaques for targeted treatment and precise diagnosis. Materials & Design 2023, 231 , 112005. https://doi.org/10.1016/j.matdes.2023.112005
    Load more citations

    ACS Nano

    Cite this: ACS Nano 2018, 12, 9, 8943–8960
    Click to copy citationCitation copied!
    https://doi.org/10.1021/acsnano.8b02037
    Published August 16, 2018
    Copyright © 2018 American Chemical Society

    Article Views

    12k

    Altmetric

    -

    Citations

    Learn about these metrics

    Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.

    Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.

    The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated.